Albumin-myosteatosis gauge as predictor of survival time in patients with lung cancer treated with immune checkpoint inhibitors
Fields of Study & Subjects
Inflammatory Biomarkers in Disease Prognosis
Cancer Immunotherapy and Biomarkers
Lung Cancer Research Studies
Publication details
- Journal / source
- Clinical Nutrition ESPEN
- Publisher
- Elsevier BV
- Volume
- 73
- Pages
- 103288–103288
- Publication date
- 12 April 2026
- Language
- EN